Publications by authors named "Zhengning Lin"

Claim this Profile
R
Response to Letter to the Editor From Malozowski: "Weekly Lonapegsomatropin in Treatment-Naïve Children With Growth Hormone Deficiency: The Phase 3 heiGHt Trial".
Paul S Thornton, Aristides K Maniatis, Elena Aghajanova, Elena Chertok, Zhengning Lin

J Clin Endocrinol Metab· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to Letter to the Editor From L. Sävendahl et al: "Weekly Lonapegsomatropin in Treatment-Naïve Children With Growth Hormone Deficiency: The Phase 3 heiGHt Trial".
Paul S Thornton, Aristides K Maniatis, Elena Aghajanova, Elena Chertok, Elpis Vlachopapadopoulou, Zhengning Lin

J Clin Endocrinol Metab· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Average IGF-1 Prediction for Once-Weekly Lonapegsomatropin in Children With Growth Hormone Deficiency.
Zhengning Lin, Aimee D Shu, Mark Bach, Bradley S Miller, Alan D Rogol

J Endocr Soc· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Weekly Lonapegsomatropin in Treatment-Naïve Children With Growth Hormone Deficiency: The Phase 3 heiGHt Trial.
Paul S Thornton, Aristides K Maniatis, Elena Aghajanova, Elena Chertok, Elpis Vlachopapadopoulou, Zhengning Lin

J Clin Endocrinol Metab· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Psychometric validation of the Hypoparathyroidism Patient Experience Scales (HPES).
Meryl Brod, Lori McLeod, Denka Markova, Jill Gianettoni, Sanchita Mourya, Zhengning Lin

J Patient Rep Outcomes· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Placebo-controlled Phase 2 Trial of Drisapersen for Duchenne Muscular Dystrophy.
Craig M McDonald, Brenda Wong, Kevin M Flanigan, Rosamund Wilson, Sjef de Kimpe, Zhengning Lin

Ann Clin Transl Neurol· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized placebo-controlled phase 3 trial of an antisense oligonucleotide, drisapersen, in Duchenne muscular dystrophy.
Nathalie Goemans, Eugenio Mercuri, Elena Belousova, Hirofumi Komaki, Alberto Dubrovsky, Zhengning Lin

Neuromuscul Disord· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of continued treatment with pirfenidone following clinically meaningful declines in forced vital capacity: analysis of data from three phase 3 trials in patients with idiopathic pulmonary fibrosis.
Steven D Nathan, Carlo Albera, Williamson Z Bradford, Ulrich Costabel, Roland M du Bois, Zhengning Lin

Thorax· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety of pirfenidone in patients with idiopathic pulmonary fibrosis: integrated analysis of cumulative data from 5 clinical trials.
Lisa Lancaster, Carlo Albera, Williamson Z Bradford, Ulrich Costabel, Roland M du Bois, Zhengning Lin

BMJ Open Respir Res· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A double-blind, randomized, multicenter, dose-ranging study to evaluate the safety and efficacy of fospropofol disodium as an intravenous sedative for colonoscopy in high-risk populations.
Sergio D Bergese, Poorvi Dalal, Rashmi Vandse, Andrew Satlin, Zhengning Lin

Am J Ther· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reduced hypoglycemia risk with insulin glargine: a meta-analysis comparing insulin glargine with human NPH insulin in type 2 diabetes.
Julio Rosenstock, George Dailey, Massimo Massi-Benedetti, Andreas Fritsche, Zhengning Lin

Diabetes Care· April 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis